Jump to content

User:Dss2016/sandbox/Systems Oncology

From Wikipedia, the free encyclopedia

</ref>

Systems Oncology
Company typePrivate
IndustryBiotechnology
Founded2015
FounderSpyro Mousses
HeadquartersScottsdale, Arizona, United States
Websitehttp://www.systemsoncology.com/


Systems Oncology

[edit]

Systems Oncology LLC is an Arizona-based biotechnology company that discoveries and develops cancer therapeutics. The company applies cognitive computing and multi-scalar systems modeling to mine massive data sets and uncover hidden therapeutic insights for cancer, and partners with academic institutes and pharmaceutical companies to accelerate development of cancer treatments [1].

In February 2017, Systems Oncology licensed in a patented drug compound from the University of Wisconsin-Milwaukee Research Foundation [2,3]. The compound alters the VDR’s action selectively, and block the local inactivation of vitamin D around the tumor micro-environment, without interfering with the systemic calcium regulation needed for normal health. Current evidence shows the compound has safely and effectively suppressed tumors in animal models [4]. Systems Oncology plans to work with pharmaceutical partners to co-develop this new agent into a cancer therapy [5].

References

[edit]

1. http://www.newswise.com/articles/uwm-research-foundation-licenses-a-novel-cancer-drug-compound-to-systems-oncology

2. http://uwm.edu/news/uwm-research-foundation-licenses-novel-cancer-drug/

3. http://www.arnoldgroup.org

4. https://www.sciencedaily.com/releases/2017/02/170208151438.htm

5. http://collegenewsupdates.com/uwm-research-foundation-licenses-novel-cancer-drug/

[edit]